HEADER HYDROLASE 14-MAY-19 6OYL TITLE THE STRUCTURE OF THE PP2A B56 SUBUNIT KIF4A COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN PHOSPHATASE 2A 56 KDA REGULATORY COMPND 3 SUBUNIT GAMMA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 62-411; COMPND 6 SYNONYM: PP2A B SUBUNIT ISOFORM B'-GAMMA,PP2A B SUBUNIT ISOFORM B56- COMPND 7 GAMMA,PP2A B SUBUNIT ISOFORM PR61-GAMMA,PP2A B SUBUNIT ISOFORM R5- COMPND 8 GAMMA,RENAL CARCINOMA ANTIGEN NY-REN-29; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: CHROMOSOME-ASSOCIATED KINESIN KIF4A; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: C-TERMINAL PEPTIDE (UNP RESIDUES 1192-1232); COMPND 14 SYNONYM: CHROMOKINESIN-A; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPP2R5C, KIAA0044; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: KIF4A, KIF4; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SER/THR PHOSPHATASE, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR X.WANG,R.PAGE,W.PETI REVDAT 3 11-OCT-23 6OYL 1 REMARK REVDAT 2 01-APR-20 6OYL 1 JRNL REVDAT 1 25-MAR-20 6OYL 0 JRNL AUTH X.WANG,D.H.GARVANSKA,I.NASA,Y.UEKI,G.ZHANG,A.N.KETTENBACH, JRNL AUTH 2 W.PETI,J.NILSSON,R.PAGE JRNL TITL A DYNAMIC CHARGE-CHARGE INTERACTION MODULATES PP2A:B56 JRNL TITL 2 SUBSTRATE RECRUITMENT. JRNL REF ELIFE V. 9 2020 JRNL REFN ESSN 2050-084X JRNL PMID 32195664 JRNL DOI 10.7554/ELIFE.55966 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.52 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 11868 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 581 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.5180 - 4.9941 0.99 3049 150 0.1919 0.1959 REMARK 3 2 4.9941 - 3.9651 0.99 2903 146 0.2176 0.2315 REMARK 3 3 3.9651 - 3.4643 1.00 2879 144 0.2403 0.2771 REMARK 3 4 3.4643 - 3.1500 0.86 2456 141 0.2976 0.3436 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2881 REMARK 3 ANGLE : 0.652 3909 REMARK 3 CHIRALITY : 0.040 429 REMARK 3 PLANARITY : 0.006 497 REMARK 3 DIHEDRAL : 14.986 1744 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OYL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1000241600. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11932 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.148 REMARK 200 RESOLUTION RANGE LOW (A) : 39.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 8.200 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 5K6S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.75, 0.8 M LITHIUM REMARK 280 CHLORIDE, 8% PEG8000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.64500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.90400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.01850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.90400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.64500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.01850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 26 REMARK 465 HIS A 27 REMARK 465 MET A 28 REMARK 465 GLY A 29 REMARK 465 SER A 30 REMARK 465 ARG A 31 REMARK 465 ASP A 32 REMARK 465 VAL A 33 REMARK 465 PRO A 34 REMARK 465 PRO A 35 REMARK 465 ALA A 36 REMARK 465 SER A 110 REMARK 465 SER A 111 REMARK 465 ASN A 112 REMARK 465 PRO A 113 REMARK 465 THR A 114 REMARK 465 GLY A 115 REMARK 465 ALA A 116 REMARK 465 GLU A 117 REMARK 465 PHE A 118 REMARK 465 ASP A 119 REMARK 465 PRO A 120 REMARK 465 GLU A 121 REMARK 465 GLU A 122 REMARK 465 ASP A 123 REMARK 465 GLU A 124 REMARK 465 PRO A 125 REMARK 465 THR A 126 REMARK 465 LEU A 127 REMARK 465 SER A 378 REMARK 465 LYS A 379 REMARK 465 THR A 380 REMARK 465 GLY B 1189 REMARK 465 HIS B 1190 REMARK 465 MET B 1191 REMARK 465 GLU B 1192 REMARK 465 LEU B 1193 REMARK 465 LYS B 1194 REMARK 465 HIS B 1195 REMARK 465 VAL B 1196 REMARK 465 ALA B 1197 REMARK 465 THR B 1198 REMARK 465 GLU B 1199 REMARK 465 TYR B 1200 REMARK 465 GLN B 1201 REMARK 465 GLU B 1202 REMARK 465 ASN B 1203 REMARK 465 LYS B 1204 REMARK 465 ALA B 1205 REMARK 465 PRO B 1206 REMARK 465 GLY B 1207 REMARK 465 LYS B 1208 REMARK 465 LYS B 1209 REMARK 465 LYS B 1210 REMARK 465 LYS B 1211 REMARK 465 ARG B 1212 REMARK 465 ALA B 1213 REMARK 465 LEU B 1214 REMARK 465 ALA B 1215 REMARK 465 SER B 1216 REMARK 465 ASN B 1217 REMARK 465 THR B 1218 REMARK 465 SER B 1219 REMARK 465 PHE B 1220 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 40 CE NZ REMARK 470 LEU A 52 CG CD1 CD2 REMARK 470 VAL A 56 CG1 CG2 REMARK 470 GLU A 128 CG CD OE1 OE2 REMARK 470 LYS A 295 CG CD CE NZ REMARK 470 PHE B1221 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 58 79.33 -159.79 REMARK 500 ARG A 105 -159.32 -140.63 REMARK 500 ALA A 130 49.73 -84.83 REMARK 500 LEU A 237 -104.88 -14.79 REMARK 500 VAL A 250 -55.12 -133.59 REMARK 500 SER A 259 32.15 -79.48 REMARK 500 LYS A 277 -71.16 -70.78 REMARK 500 PRO A 294 95.59 -62.36 REMARK 500 PRO A 299 -8.77 -59.91 REMARK 500 ILE A 323 20.43 -142.42 REMARK 500 ASN A 362 30.21 -141.47 REMARK 500 SER B1222 -141.41 65.15 REMARK 500 REMARK 500 REMARK: NULL DBREF 6OYL A 31 380 UNP Q13362 2A5G_HUMAN 62 411 DBREF 6OYL B 1192 1232 UNP O95239 KIF4A_HUMAN 1192 1232 SEQADV 6OYL GLY A 26 UNP Q13362 EXPRESSION TAG SEQADV 6OYL HIS A 27 UNP Q13362 EXPRESSION TAG SEQADV 6OYL MET A 28 UNP Q13362 EXPRESSION TAG SEQADV 6OYL GLY A 29 UNP Q13362 EXPRESSION TAG SEQADV 6OYL SER A 30 UNP Q13362 EXPRESSION TAG SEQADV 6OYL GLY B 1189 UNP O95239 EXPRESSION TAG SEQADV 6OYL HIS B 1190 UNP O95239 EXPRESSION TAG SEQADV 6OYL MET B 1191 UNP O95239 EXPRESSION TAG SEQADV 6OYL LEU B 1224 UNP O95239 CYS 1224 ENGINEERED MUTATION SEQADV 6OYL GLU B 1225 UNP O95239 SER 1225 ENGINEERED MUTATION SEQADV 6OYL PRO B 1231 UNP O95239 ALA 1231 ENGINEERED MUTATION SEQADV 6OYL GLU B 1232 UNP O95239 HIS 1232 ENGINEERED MUTATION SEQRES 1 A 355 GLY HIS MET GLY SER ARG ASP VAL PRO PRO ALA ASP GLN SEQRES 2 A 355 GLU LYS LEU PHE ILE GLN LYS LEU ARG GLN CYS CYS VAL SEQRES 3 A 355 LEU PHE ASP PHE VAL SER ASP PRO LEU SER ASP LEU LYS SEQRES 4 A 355 TRP LYS GLU VAL LYS ARG ALA ALA LEU SER GLU MET VAL SEQRES 5 A 355 GLU TYR ILE THR HIS ASN ARG ASN VAL ILE THR GLU PRO SEQRES 6 A 355 ILE TYR PRO GLU VAL VAL HIS MET PHE ALA VAL ASN MET SEQRES 7 A 355 PHE ARG THR LEU PRO PRO SER SER ASN PRO THR GLY ALA SEQRES 8 A 355 GLU PHE ASP PRO GLU GLU ASP GLU PRO THR LEU GLU ALA SEQRES 9 A 355 ALA TRP PRO HIS LEU GLN LEU VAL TYR GLU PHE PHE LEU SEQRES 10 A 355 ARG PHE LEU GLU SER PRO ASP PHE GLN PRO ASN ILE ALA SEQRES 11 A 355 LYS LYS TYR ILE ASP GLN LYS PHE VAL LEU GLN LEU LEU SEQRES 12 A 355 GLU LEU PHE ASP SER GLU ASP PRO ARG GLU ARG ASP PHE SEQRES 13 A 355 LEU LYS THR THR LEU HIS ARG ILE TYR GLY LYS PHE LEU SEQRES 14 A 355 GLY LEU ARG ALA TYR ILE ARG LYS GLN ILE ASN ASN ILE SEQRES 15 A 355 PHE TYR ARG PHE ILE TYR GLU THR GLU HIS HIS ASN GLY SEQRES 16 A 355 ILE ALA GLU LEU LEU GLU ILE LEU GLY SER ILE ILE ASN SEQRES 17 A 355 GLY PHE ALA LEU PRO LEU LYS GLU GLU HIS LYS ILE PHE SEQRES 18 A 355 LEU LEU LYS VAL LEU LEU PRO LEU HIS LYS VAL LYS SER SEQRES 19 A 355 LEU SER VAL TYR HIS PRO GLN LEU ALA TYR CYS VAL VAL SEQRES 20 A 355 GLN PHE LEU GLU LYS ASP SER THR LEU THR GLU PRO VAL SEQRES 21 A 355 VAL MET ALA LEU LEU LYS TYR TRP PRO LYS THR HIS SER SEQRES 22 A 355 PRO LYS GLU VAL MET PHE LEU ASN GLU LEU GLU GLU ILE SEQRES 23 A 355 LEU ASP VAL ILE GLU PRO SER GLU PHE VAL LYS ILE MET SEQRES 24 A 355 GLU PRO LEU PHE ARG GLN LEU ALA LYS CYS VAL SER SER SEQRES 25 A 355 PRO HIS PHE GLN VAL ALA GLU ARG ALA LEU TYR TYR TRP SEQRES 26 A 355 ASN ASN GLU TYR ILE MET SER LEU ILE SER ASP ASN ALA SEQRES 27 A 355 ALA LYS ILE LEU PRO ILE MET PHE PRO SER LEU TYR ARG SEQRES 28 A 355 ASN SER LYS THR SEQRES 1 B 44 GLY HIS MET GLU LEU LYS HIS VAL ALA THR GLU TYR GLN SEQRES 2 B 44 GLU ASN LYS ALA PRO GLY LYS LYS LYS LYS ARG ALA LEU SEQRES 3 B 44 ALA SER ASN THR SER PHE PHE SER GLY LEU GLU PRO ILE SEQRES 4 B 44 GLU GLU GLU PRO GLU FORMUL 3 HOH *7(H2 O) HELIX 1 AA1 ASP A 37 CYS A 49 1 13 HELIX 2 AA2 ASP A 58 ASN A 83 1 26 HELIX 3 AA3 PRO A 90 PHE A 104 1 15 HELIX 4 AA4 ALA A 130 SER A 147 1 18 HELIX 5 AA5 GLN A 151 LYS A 156 1 6 HELIX 6 AA6 ASP A 160 LEU A 170 1 11 HELIX 7 AA7 PHE A 171 SER A 173 5 3 HELIX 8 AA8 ASP A 175 PHE A 193 1 19 HELIX 9 AA9 LEU A 196 TYR A 213 1 18 HELIX 10 AB1 GLY A 220 ASN A 233 1 14 HELIX 11 AB2 LYS A 240 VAL A 250 1 11 HELIX 12 AB3 LEU A 252 LYS A 258 5 7 HELIX 13 AB4 SER A 259 ASP A 278 1 20 HELIX 14 AB5 LEU A 281 TRP A 293 1 13 HELIX 15 AB6 LYS A 300 ASP A 313 1 14 HELIX 16 AB7 GLU A 316 VAL A 321 1 6 HELIX 17 AB8 ILE A 323 SER A 336 1 14 HELIX 18 AB9 HIS A 339 TYR A 348 1 10 HELIX 19 AC1 TYR A 349 ASN A 351 5 3 HELIX 20 AC2 ASN A 352 ASP A 361 1 10 HELIX 21 AC3 ASN A 362 PHE A 371 1 10 CRYST1 53.290 108.037 117.808 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018765 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008488 0.00000